The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
Open accessAbstract
Objective: To assess the clinical value of 18 F‐fluorodeoxyglucose (FDG) positron emission tomography (PET) in a prospective cohort of patients with large vessel vasculitis (LVV) and comparator subjects. Methods: Patients with Takayasu arteritis and giant cell arteritis were studied, along with a comparator group consisting of patients with hyperlipidemia, patients with diseases that mimic LVV, and healthy controls. Participants underwent clinical evaluation and FDG‐PET imaging, and patients with LVV underwent serial imaging at 6‐month intervals. We calculated sensitivity and specificity of FDG‐PET interpretation for distinguishing patients with clinically active LVV from comparator subjects and from patients with disease in clinical remission. A qualitative summary score based on global arterial FDG uptake, the PET Vascular Activity Score (PETVAS), was used to study associations between activity on PET scan and clinical characteristics and to predict relapse. Results: A total of 170 FDG‐PET scans were performed in 115 participants (56 patients with LVV and 59 comparator subjects). FDG‐PET distinguished patients with clinically active LVV from comparator subjects with a sensitivity of 85% (95% confidence interval [95% CI] 69, 94) and a specificity of 83% (95% CI 71, 91). FDG‐PET scans were interpreted as active vasculitis in most patients with LVV in clinical remission (41 of 71 [58%]). Clinical disease activity status, disease duration, body mass index, and glucocorticoid use were independently associated with activity on PET scan. Among patients who underwent PET during clinical remission, future clinical relapse was more common in patients with a high PETVAS than in those with a low PETVAS (55% versus 11%; P = 0.03) over a median follow‐up period of 15 months. Conclusion: FDG‐PET provides information about vascular inflammation that is complementary to, and distinct from, clinical assessment in LVV. FDG‐PET scan activity during clinical remission was associated with future clinical relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Self-citationThe American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330810 · Cited by 2,539
The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
Arend, W. P., Michel, B. A., Bloch, D. A., Hunder, G. G., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330811 · Cited by 2,267
Kerr, G. S., Hallahan, C. W., Giordano, J. M., Leavitt, R. Y., Fauci, A. S., Rottem, M., & Hoffman, G. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00004 · Cited by 1,625
Positron-Emission Tomography and Assessment of Cancer Therapy
Juweid, M. E., & Cheson, B. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050276 · Cited by 750
EULAR recommendations for the management of large vessel vasculitis
Mukhtyar, C. B., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W. L., Hauser, T., Hellmich, B., Jayne, D. R. W., Kallenberg, C. G. M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088351 · Cited by 673
Self-citationBlockmans, D., Ceuninck, L. D., Vanderschueren, S., Knockaert, D., Mortelmans, L., & Bobbaers, H. (2006) · Arthritis Care & Research · doi:10.1002/art.21699 · Cited by 628
Walter, M. A., Melzer, R., Schindler, C. J. A., Müller‐Brand, J., Tyndall, A., & Nitzsche, E. U. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1757-9 · Cited by 357
Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages
Folco, E. J., Sheikine, Y., Rocha, V. Z., Christen, T., Shvartz, E., Sukhova, G. K., Di Carli, M. F., & Libby, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.044 · Cited by 326
Unizony, S., Arias‐Urdaneta, L., Miloslavsky, E., Arvikar, S., Khosroshahi, A., Keroack, B., Stone, J. R., & Stone, J. H. (2012) · Arthritis Care & Research · doi:10.1002/acr.21750 · Cited by 272
Cited by
Maz, M., Chung, S. A., Abril, A., Langford, C. A., Gorelik, M., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41774 · Cited by 654
Self-citationDejaco, C., Ramiro, S., Bond, M., Bosch, P., Ponte, C., Mackie, S. L., Bley, T. A., Blockmans, D., Brolin, S., Bolek, E. C., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224543 · Cited by 389
Fitbit-based interventions for healthy lifestyle outcomes: systematic review and meta-analysis
Ringeval, M., Wagner, G., Denford, J., Paré, G., & Kitsiou, S. (2020) · Journal of Medical Internet Research · doi:10.2196/23954 · Cited by 225
Metadata
- Authors
- Grayson, P. C., Alehashemi, S., Bagheri, A. A., Civelek, A. C., Cupps, T. R., Kaplan, M. J., Malayeri, A. A., Merkel, P. A., Novakovich, E., Bluemke, D. A., & Ahlman, M. A.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2018-02-06
- Volume
- 70
- Issue
- 3
- Pages
- 439-449
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W2769898966
- Cited by
- 352
- References
- 20
- FWCI
- 22.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.